BRAF V600E MUTATION POSITIVE
Clinical trials for BRAF V600E MUTATION POSITIVE explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E MUTATION POSITIVE trials appear
Sign up with your email to follow new studies for BRAF V600E MUTATION POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists try drug duo to Re-Sensitize stubborn thyroid tumors
Disease control CompletedThis early-stage study tested a combination of two drugs, vemurafenib and copanlisib, in patients with a specific type of advanced thyroid cancer that had stopped responding to standard radioactive iodine therapy. The main goals were to find the safest dose of the drug combinatio…
Matched conditions: BRAF V600E MUTATION POSITIVE
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Doctors scrutinize past treatments for Tough-to-Treat colon cancer
Knowledge-focused CompletedThis study looked back at the medical records of 274 European patients with a specific, aggressive form of metastatic colon cancer (with a BRAF V600E mutation). The goal was to understand what treatments doctors actually used in the real world between 2016 and 2018, and how well …
Matched conditions: BRAF V600E MUTATION POSITIVE
Sponsor: Pierre Fabre Medicament • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:03 UTC